Align Technology, Inc.
ALGNHealthcareNASDAQMedical Instruments & Supplies · Last scanned May 29, 2026
Scan Results
Daily timeframePart of the healthcare sector, Align Technology, Inc. (ALGN) is listed under Medical Instruments & Supplies. With a market capitalization of $12.53B, it sits in large-cap territory. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth.
Market Cap
$12.53B
Beta
1.70
P/E (TTM)
29.40
P/E (Fwd)
14.13
EPS (TTM)
$5.95
EPS (Fwd)
$12.38
ROE
10.8%
ROA
7.3%
Cash
$1.06B
Total Debt
$116.0M
Free CF
$539.0M
52W Change
-2.0%
Annual Financials
Cash vs Debt
Align Technology, Inc. holds $1.06B in cash against $116.0M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Free cash flow comes in at $539.0M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 10.8%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 7.3% suggests reasonable efficiency in deploying the company's asset base. Revenue has been relatively flat, moving from $3.73B (2022) to $4.03B (2025).
A beta of 1.70 means ALGN is more volatile than average. Investors should be prepared for wider price swings relative to broader indices. With cash comfortably exceeding debt, ALGN has financial flexibility that may help navigate uncertain periods. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Align Technology, Inc. and its sector.